Ocular delivery of proteins and peptides: Challenges and novel formulation approaches

A Mandal, D Pal, V Agrahari, HM Trinh… - Advanced drug delivery …, 2018 - Elsevier
The impact of proteins and peptides on the treatment of various conditions including ocular
diseases over the past few decades has been advanced by substantial breakthroughs in …

Development of macromolecular prodrug for rheumatoid arthritis

F Yuan, L Quan, L Cui, SR Goldring, D Wang - Advanced drug delivery …, 2012 - Elsevier
Rheumatoid arthritis (RA) is a chronic autoimmune disease that is considered to be one of
the major public health problems worldwide. The development of therapies that target tumor …

Superstructured poly (amidoamine) dendrimer-based nanoconstructs as platforms for cancer nanomedicine: A concise review

C Song, M Shen, J Rodrigues, S Mignani… - Coordination Chemistry …, 2020 - Elsevier
Abstract Poly (amidoamine)(PAMAM) dendrimers, as a family of synthetic macromolecules
with highly branched interiors, abundant surface functional groups, and well-controlled …

PAMAM dendrimer nanomolecules utilized as drug delivery systems for potential treatment of glioblastoma: a systematic review

M Fana, J Gallien, B Srinageshwar… - International journal …, 2020 - Taylor & Francis
Glioblastoma (GB) is a grade IV astrocytoma that maintains a poor prognosis with respect to
current treatment options. Despite major advancements in the fields of surgery and …

Targeting glioblastoma: Advances in drug delivery and novel therapeutic approaches

E Yeini, P Ofek, N Albeck… - Advanced …, 2021 - Wiley Online Library
Glioblastoma (GB) is the most lethal type of primary tumor in the central nervous system.
Current treatments include surgical resection followed by chemotherapy and radiotherapy …

[HTML][HTML] Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?

W Echavidre, V Picco, M Faraggi, C Montemagno - Pharmaceutics, 2022 - mdpi.com
Glioblastoma (GBM), the most common primary malignant brain tumor, is associated with a
dismal prognosis. Standard therapies including maximal surgical resection, radiotherapy …

Multimodal tumor-targeting peptides functionalized with both a radio-and a fluorescent label

J Kuil, AH Velders, FWB van Leeuwen - Bioconjugate chemistry, 2010 - ACS Publications
The use of monolabeled tumor-targeting peptides for molecular imaging is widespread.
However, it is often desirable to use the same compound for different clinical applications …

[PDF][PDF] RGD‐modified PEG‐PAMAM‐DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells

S Zhu, L Qian, M Hong, L Zhang, Y Pei, Y Jiang - Advanced …, 2011 - academia.edu
Selective targeting of anticancer drugs to the tumor site is critical for effective cancer therapy.
The cell adhesion molecule integrin α vβ 3 is not readily detectable in quiescent vessels but …

Multivalent ligand: design principle for targeted therapeutic delivery approach

C Chittasupho - Therapeutic delivery, 2012 - Taylor & Francis
Multivalent interactions of biological molecules play an important role in many biochemical
events. A multivalent ligand comprises of multiple copies of ligands conjugated to scaffolds …

Peptide-and saccharide-conjugated dendrimers for targeted drug delivery: a concise review

J Liu, WD Gray, ME Davis, Y Luo - Interface Focus, 2012 - royalsocietypublishing.org
Dendrimers comprise a category of branched materials with diverse functions that can be
constructed with defined architectural and chemical structures. When decorated with …